The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said on ...
University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub ...
Immune responses against serogroups A, C, W, and Y were noninferior between the MenABCWY and MenACWY-CRM vaccines in young adults and adolescents.
HealthDay on MSN15d
FDA Approves More Broadly Protective Meningococcal VaccineThe US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.
1d
News Medical on MSNMeningococcal Vaccine Proves Safe, Effective for InfantsUniversity of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects ...
Since the introduction of the MenA conjugate vaccine in the African meningitis belt through mass vaccination campaigns and its inclusion in the Essential Program on Immunization (EPI), cases of ...
The CDC’s Advisory Committee on Immunization Practices is expected to provide recommendations on the appropriate use of Penmenvy at its meeting on February 26, 2025. The Food and Drug ...
Doctors share concerns over how declining rates of vaccinations could put people at risk for Meningococcal disease and Measles.
We welcome new tools to help protect more adolescents from meningococcal disease. Pentavalent MenABCWY vaccines could help address the disease by providing protection against the five vaccine ...
The CDC is planning a large study on potential vaccinAutism's links, despite extensive research dismissing any connection.
Penmenvy protects against meningococcal serotypes A, B, C, W and Y. CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent ...
The vaccine targets five major serogroups of Neisseria meningitidis (A, B, C, W, and Y) which commonly cause invasive meningococcal disease (IMD).1,2 Tony Wood, Chief Scientific Officer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results